Description |
1 online resource (xiv, 244 pages, [1] pages) : illustrations (some color) |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
|
data file rda |
Series |
Wiley series in drug discovery and development |
|
Wiley series in drug discovery and development.
|
Bibliography |
Includes bibliographical references and index. |
Contents |
In vitro evaluation of metabolic drug-drug interactions: concepts and practice / Albert P. Li -- In vitro approaches to anticipating clinical drug interactions / Laurie P. Volak, David J. Greenblatt, Lisa L. von Moltke -- Inhibition of drug metabolizing enzymes and drug-drug interactions in drug discovery and development / R. Scott Obach -- Mechanism-based CYP inhibition: enzyme kinetics, assays, and prediction of human drug-drug interactions / Magang Shou -- Genomic approaches to drug-drug interactions / Yi Yang, Jeffrey F. Waring -- Transporters and drug interactions / Yoshihisa Shitara, Toshiharu Horie, and Yuichi Sugiyama -- Transporter-mediated drug interactions: molecular mechanisms and clinical implications / Jiunn H. Lin -- Recent case studies of clinically significant drug-drug interactions and the limits of in vitro prediction methodology / R.H. Levy, I. Ragueneau-Majlessi, C. Collins -- US regulatory perspective: drug-drug interactions / John Strong and Shiew-Mei Huang -- Herbal drug interactions: a Canadian perspective / Brian C. Foster. |
Note |
Print version record. |
Summary |
Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage. |
Language |
English. |
Subject |
Drug interactions.
|
|
Drug development.
|
|
Drug Interactions. |
|
Chemistry, Pharmaceutical. |
|
Interactions médicamenteuses.
|
|
MEDICAL -- Pharmacology.
|
|
Drug development. (OCoLC)fst00898670
|
|
Drug interactions. (OCoLC)fst00898681
|
|
Arzneimittelentwicklung
|
|
Arzneimittelwechselwirkung
|
Genre/Form |
Electronic books.
|
|
Electronic books.
|
Added Author |
Li, A. P.
|
Other Form: |
Print version: Drug-drug interactions in pharmaceutical development. Hoboken, N.J. : Wiley-interscience, ©2008 (DLC) 2007015878 |
ISBN |
9780470187913 (electronic bk.) |
|
0470187913 (electronic bk.) |
|
9780470187920 |
|
0470187921 |
|
9780471794417 (cloth) |
|
0471794414 (cloth) |
|
1282022067 |
|
9781282022065 |
|
9786612022067 |
|
661202206X |
Standard No. |
10.1002/9780470187920 doi |
|
AU@ 000043398316 |
|
AU@ 000051544877 |
|
CHNEW 000935367 |
|
CHVBK 480157111 |
|
DEBBG BV043146671 |
|
DEBBG BV043391197 |
|
DEBBG BV044134602 |
|
DEBSZ 422015709 |
|
DEBSZ 484983059 |
|
NZ1 13340219 |
|